Skip to main content

Advertisement

SpringerLink
Log in

Anti-CCP in systemic lupus erythematosus patients: a cross sectional study in Brazilian patients

  • Brief Report
  • Published:
Clinical Rheumatology Aims and scope Submit manuscript

Abstract

Recently, it has been found that some lupus patients may have anti-cyclic citrullinated peptide antibodies (anti-CCP), although the clinical significance of such finding is not well established. Systemic lupus erythematosus (SLE) patients may have joint complaints that are very similar to those observed in rheumatoid arthritis (RA). In early stages of disease, this form of arthritis can be difficult to differentiate from RA, so it is not rare that some SLE patients are initially misdiagnosed to have this disease. This study aims to investigate the prevalence of anti-CCP in SLE patients from Southern Brazil and its association with clinical and serological profiles. One hundred nine SLE patients were studied for anti-CCP and compared with data of 156 RA patients and 100 healthy volunteers. Comparison of clinical and autoantibody profile of anti-CCP-positive and anti-CCP-negative SLE patients was done. All SLE patients positive of anti-CCP were submitted to hand and feet X-rays. Anti-CCP was positive in 15 of 109 SLE patients, and one of them had confirmed the diagnosis of rhupus. This prevalence was significantly higher than in healthy controls (p = 0.0004) and lower than in RA patients (p < 0.0001). No relationship could be found with clinical profile, including joint complaints. SLE patients with anti-CCP had higher prevalence of anti-Ro (p = 0.02) and anti-La (p = 0.004) autoantibodies, in comparison with those negative to anti-CCP. We found that 13.7 % of Brazilian patients with SLE have positive anti-CCP. Patients with anti-CCP showed higher prevalence of anti-Ro and anti-La autoantibodies than those negative for anti-CCP. Only a careful and prolonged follow-up will reveal the real clinical value of these markers in each patient individually.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Di Cesare PE, Valle CJD, Zuckerman JD (2004) Articular manifestations of Systemic lupus erythematosus. In: Lahita RG (ed) Systemic lupus erythematosus. Elsevier, San Diego, pp 1037–1063

    Chapter  Google Scholar 

  2. Aitcheson CT, Peebles C, Joslin F, Tan EM (1980) Characteristics of antinuclear antibodies in rheumatoid arthritis. Arthritis Rheum 23:528–537

    Article  PubMed  CAS  Google Scholar 

  3. De La Torre IG, Miranda-Mendez L (1982) Studies of antinuclear antibodies in rheumatoid arthritis patients. J Rheumatol 42:603–606

    Google Scholar 

  4. Caspi D, Elkayan O, Eisinger M, Vardinon N, Yaron M, Burke M (2001) Clinical significance of low titer antinuclear antibodies in early rheumatoid arthritis: implications on the presentation and long term course of the disease. Rheumatol Int 20:43–47

    Article  PubMed  CAS  Google Scholar 

  5. Quismoro FP (1993) Other serologic abnormalities in SLE. In: Wallace DJ, Hahn B (eds) Dubois systemic lupus erythematosus. Lea & Febiger, Philadelphia, pp 264–276

    Google Scholar 

  6. Ioan-Facsinay A, Willemze A, Robinson DB, Peschken CA, Markland J, Van der Woude D et al (2008) Marked differences in fine specificity and isotype usage of the anti-citrullinated protein antibody in health and disease. Arthritis Rheum 58:3000–3008

    Article  PubMed  Google Scholar 

  7. Lee AN, Beck CE, Hall M (2008) Rheumatoid factor and anti-CCP antibodies in rheumatoid arthritis: a review. Clin Lab Sci 21:15–18

    PubMed  CAS  Google Scholar 

  8. Nishimura K, Sugiyama D, Kogata Y, Tsuji G, Nakazawa T, Kawano S et al (2007) Meta-analysis: diagnostic accuracy of anti-cyclic citrullinated peptide antibody and rheumatoid factor for rheumatoid arthritis. Ann Intern Med 146:797–808

    Article  PubMed  Google Scholar 

  9. Avouac J, Gossec L, Dougados M (2006) Diagnostic and predictive value of anti-cyclic citrullinated protein antibodies in rheumatoid arthritis: a systematic literature review. Ann Rheum Dis 65:845–851

    Article  PubMed  CAS  Google Scholar 

  10. Singh U, Singh S, Singh NK, Verma PK, Singh S (2011) Anti cyclic citrullinated peptide autoantibodies in systemic lupus erythematosus. Rheumatol Int 31:765–767

    Article  PubMed  CAS  Google Scholar 

  11. Zhao Y, Li J, Li X, Li L, Li Z (2009) What can we learn from the presence of anti-cyclic citrullinated peptide antibodies in systemic lupus erythematosus? Joint Bone Spine 76:501–507

    Article  PubMed  CAS  Google Scholar 

  12. Qing Y-F, Zhang Q-B, Zhou J-G, Yuan G-H, Wei J, Xing Y et al (2009) The detecting and clinical value of anti cyclic citrullinated peptide antibodies in patients with systemic lupus erythematosus. Lupus 18:713–717

    Article  PubMed  CAS  Google Scholar 

  13. Kakumanu P, Sobel ES, Narain S, Akaogi J, Yamasaki Y, Segal MS et al (2009) Citrulline dependence of anti cyclic citrullinated peptide antibodies in systemic lupus erythematosus as a marker of deforming/erosive arthritis. J Rheumatol 36:2682–2690

    Article  PubMed  CAS  Google Scholar 

  14. Damian-Abrego GN, Cabiedes J, Cabral AR (2008) Anti citrullinated peptide antibodies in lupus patients with or without deforming arthropathy. Lupus 17:300–304

    Article  PubMed  CAS  Google Scholar 

  15. Mediwake R, Isenberg DA, Schellekens GA, van Venrooij WJ (2001) Use of anti-citrullinated peptide and anti-RA33 antibodies in distinguishing erosive arthritis in patients with systemic lupus erythematosus and rheumatoid arthritis. Ann Rheum Dis 60:67–68

    Article  PubMed  CAS  Google Scholar 

  16. Taraborelli M, Inverardi F, Fredi M, Ceribelli A, Cavazzana I, Tincani A, Franceschini F (2012) Anti-cyclic citrullinated peptide antibodies in systemic lupus erythematosus patients with articular involvement: a predictive marker for erosive disease? Reumatismo 64:321–325

    Article  PubMed  CAS  Google Scholar 

  17. Hochberg MC (1997) Updating the American college of Rheumatology revised criteria for systemic lupus erythematosus. Arthritis Rheum 40:1725

    Article  PubMed  CAS  Google Scholar 

  18. Goeldner I, Skare TL, de Messias Reason IT, Nisihara RM, Silva MB, Utiyama SR (2010) Anti-Cyclic citrullinated peptide antibodies and rheumatoid factor in rheumatoid arthritis patients and relatives from Brazil. Rheumatology 49:1590–1593

    Article  PubMed  CAS  Google Scholar 

  19. Fox RI (1997) Sjögren’s syndrome. Controversies and progress. Clin Lab Med 17:431–444

    PubMed  CAS  Google Scholar 

  20. Marinez JB, Valero JS, Bautista AJ, Restrepo JF, Matteson EL, Rondon F et al (2007) Erosive arthropathy: clinical variance in lupus erythematosus and association with anti CCP case series and review of the literature. Clin Exp Rheumatol 25:47–53

    Google Scholar 

  21. Skare TS, Nisihara RM, Silva RM, Munhoz da Silva DJ, Gameiro Silva MB, Utiyama SR (2011) Anti-cyclic citrullinated peptide antibodies in adult patients with juvenile idiopathic arthritis. Clin Rheumatol 17:421–423

    Article  Google Scholar 

  22. Polimeni M, Feniman D, Skare TS, Nisihara RM (2012) Anticyclic citrullinated peptide antibodies in scleroderma patients. Clin Rheumatol 31:877–880

    Article  PubMed  CAS  Google Scholar 

  23. Alenius GM, Berglin E, Dalqvist SR (2006) Antibodies against cyclic cytrullinated peptide (CCP) in psoriatic patients with or without joint inflammation. Ann Rheum Dis 65:398–400

    Article  PubMed  CAS  Google Scholar 

  24. Senkpiehl I, Marget M, Wedler M, Jenisch S, Georgi J et al (2005) HLA-DRB1 and anti-cyclic citrullinated peptide antibody production in rheumatoid arthritis. Int Arch Allergy Immunol 137:315–318

    Article  PubMed  CAS  Google Scholar 

  25. Kakumanu P, Sobel ES, Narain S, Jun UL, Akogi K, Yamasaki Y et al (2009) Citrulline dependence of anti cyclic citrullinated peptide antibodies in systemic lupus erythematosus as a marker of deforming/erosive arthritis. J Rheumatol 36:2682–2690

    Article  PubMed  CAS  Google Scholar 

  26. Panush RS, Edwards NL, Longley S, Webster E (1988) Rhupus syndrome. Arch Intern Med 148:1633–6

    Article  PubMed  CAS  Google Scholar 

  27. Nielen MM, van Schaardenburg D, Reesink HW, van de Stadt RJ, Van der Horst-Bruinsma IE, de Kpning MH et al (2004) Specific autoantibodies precede the symptoms of rheumatoid arthritis: a study of serial measurements in blood donors. Arthritis Rheum 50:380–386

    Article  PubMed  Google Scholar 

  28. Majka DS, Deane KD, Parrish LA, Lazar AA, Barón AE, Walker CM et al (2008) Duration of preclinical RA-related autoantibody positivity increases in subjects with older age at time of disease diagnosis. Ann Rheum Dis 67:801–807

    Article  PubMed  CAS  Google Scholar 

  29. Chibnik LB, Mandi LA, Costendaber KH, Shur PH, Karlson EW (2009) Comparison of threshold cut-points and continuous measures of anti-CCP antibodies in predicting future RA. J Rheumatol 36:706–711

    Article  PubMed  CAS  Google Scholar 

  30. Lee DM, Pjillips R, Hagan EM, Chibnik LB, Costenbader KH, Shur PH (2009) Quantifying anti-cyclic citrullinated peptide titres: clinical utility and association with tobacco exposure in patients with rheumatoid arthritis. Ann Rheum Dis 68:201–208

    Article  PubMed  CAS  Google Scholar 

  31. Cavazzana I, Francheschini F, Quinzanini M, Manera C, Del Papa N, Maglione W et al (2006) Anti Ro/SS-A antibodies in rheumatoid arthritis. Clinical and immunological associations. Clin Exp Rheumatol 24:59–64

    PubMed  CAS  Google Scholar 

  32. Franchescini F, Cavazzana L (2005) Anti-Ro/SSA and La/SSB antibodies. Autoimmunity 38:55–63

    Article  Google Scholar 

  33. Schneeberger E, Citera G, Heredia M, Cocco JM (2008) Clinical significance of anti- Ro antibodies in rheumatoid arthritis. Clin Rheumatol 27:517–519

    Article  PubMed  Google Scholar 

  34. Zanlorenzi L, Azevedo LOP, Silva MB, Skare TL (2012) Anti-Ro in rheumatoid arthritis. Acta Rheum Port 37:149–151

    Google Scholar 

  35. Mohammed K, Pope J, Riche N, Brintnell W, Cairns E, Coles R et al (2009) Association of severe inflammatory polyarthritis in primary sjögren’s syndrome: clinical, serological and HLA analysis. J Rheumatol 36:1937–1942

    Article  PubMed  Google Scholar 

  36. Verpoort KN, van Gaalen FA, Mil AHMH, Schreuder GMT, Breedveld FCM, Huizinga TWJ et al (2005) Association of HLA-DR3 with anti cyclic citrullinated peptide antibody-negative rheumatoid arthritis. Arthritis Rheum 52:3058–3062

    Article  PubMed  CAS  Google Scholar 

Download references

Disclosures

None

Fundings

None

Author information

Authors and Affiliations

  1. Rheumatology Unit-Hospital Universitário Evangélico de Curitiba, Rua João Azolin, 660, 82015-040, Curitiba, Paraná, Brazil

    Thelma L. Skare, Bruno Bandolin Barbosa & Alvaro da Luz

  2. Immunopathology Laboratory-Clinical Hospital, Federal University of Paraná, Rua João Azolin, 660, 82015-040, Curitiba, Paraná, Brazil

    Renato Nisihara, Shirley Utiyama & Vanessa Picceli

  3. Positivo University, Rua João Azolin, 660, 82015-040, Curitiba, Paraná, Brazil

    Renato Nisihara

Authors
  1. Thelma L. Skare
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Renato Nisihara
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Bruno Bandolin Barbosa
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Alvaro da Luz
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Shirley Utiyama
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Vanessa Picceli
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Renato Nisihara.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Skare, T.L., Nisihara, R., Barbosa, B.B. et al. Anti-CCP in systemic lupus erythematosus patients: a cross sectional study in Brazilian patients. Clin Rheumatol 32, 1065–1070 (2013). https://doi.org/10.1007/s10067-013-2213-7

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10067-013-2213-7

Keywords

Search

Navigation